Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
Abstract: Millimeter-wave radar has attracted increasing attention for respiratory monitoring due to its non-contact operation and privacy-preserving characteristics. Nevertheless, extracting ...
Abstract: Electrodermal activity (EDA) measurement has been identified as a useful indicator for evaluating pain levels in patients. This study aims to find features of the EDA signal that influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback